<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 23 Jul 2026 12:30:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/OPKO+Health+to+Report+Second+Quarter+2026+Financial+Results+on+July+27%2C+2026/26806928.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;MIAMI, July  23, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;OPKO Health, Inc. &lt;/strong&gt;(OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets, today announced that it will report operating and financial results for the second-quarter 2026 on Monday, July 27, 2026. OPKO’s senior management will host a conference call and webcast at 4:30 p.m. ET to provide a business update, discuss results and financial guidance.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;CONFERENCE CALL &amp;amp; WEBCAST INFORMATION&lt;/strong&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;OPKO encourages participants to pre-register for the conference call using this &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=2fF-cG96jNHIfSjLAW-4uUeOcIIEx3e-D6NMKQNVWavJUeWrQPM2wxFcvpv4PZmKMKBkP7psRNguEdsxqrpomrx5UBt1DpxGmO_Y0tJmWB6QQkkxWvlgVrVXWlGszMPQ7colWa5voxT3kZwvYbJjjRKJjDjddUvpJHraynkj9agkfvXQqaXkJuOw_IADhTJ87KPygBEZNM-4kc9FW9n3iw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;link&lt;/a&gt;. Participants</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/OPKO+Health+to+Report+Second+Quarter+2026+Financial+Results+on+July+27%2C+2026/26806928.html</guid>
   <pubDate>Thu, 23 Jul 2026 12:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02783319</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/OPKO+Health+to+Report+Second+Quarter+2026+Financial+Results+on+July+27%2C+2026/26806928.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;MIAMI, July  23, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;OPKO Health, Inc. &lt;/strong&gt;(OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets, today announced that it will report operating and financial results for the second-quarter 2026 on Monday, July 27, 2026. OPKO’s senior management will host a conference call and webcast at 4:30 p.m. ET to provide a business update, discuss results and financial guidance.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;CONFERENCE CALL &amp;amp; WEBCAST INFORMATION&lt;/strong&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;OPKO encourages participants to pre-register for the conference call using this &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=2fF-cG96jNHIfSjLAW-4uUeOcIIEx3e-D6NMKQNVWavJUeWrQPM2wxFcvpv4PZmKMKBkP7psRNguEdsxqrpomrx5UBt1DpxGmO_Y0tJmWB6QQkkxWvlgVrVXWlGszMPQ7colWa5voxT3kZwvYbJjjRKJjDjddUvpJHraynkj9agkfvXQqaXkJuOw_IADhTJ87KPygBEZNM-4kc9FW9n3iw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;link&lt;/a&gt;. Participants</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/OPKO+Health+to+Report+Second+Quarter+2026+Financial+Results+on+July+27%2C+2026/26806928.html</guid>
   <pubDate>Thu, 23 Jul 2026 12:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02783319</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026</title>
   <link>http://www.streetinsider.com/Globe+Newswire/OPKO+Health+to+Report+Second+Quarter+2026+Financial+Results+on+July+27%2C+2026/26806928.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;MIAMI, July  23, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;OPKO Health, Inc. &lt;/strong&gt;(OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets, today announced that it will report operating and financial results for the second-quarter 2026 on Monday, July 27, 2026. OPKO’s senior management will host a conference call and webcast at 4:30 p.m. ET to provide a business update, discuss results and financial guidance.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;CONFERENCE CALL &amp;amp; WEBCAST INFORMATION&lt;/strong&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;OPKO encourages participants to pre-register for the conference call using this &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=2fF-cG96jNHIfSjLAW-4uUeOcIIEx3e-D6NMKQNVWavJUeWrQPM2wxFcvpv4PZmKMKBkP7psRNguEdsxqrpomrx5UBt1DpxGmO_Y0tJmWB6QQkkxWvlgVrVXWlGszMPQ7colWa5voxT3kZwvYbJjjRKJjDjddUvpJHraynkj9agkfvXQqaXkJuOw_IADhTJ87KPygBEZNM-4kc9FW9n3iw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;link&lt;/a&gt;. Participants</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/OPKO+Health+to+Report+Second+Quarter+2026+Financial+Results+on+July+27%2C+2026/26806928.html</guid>
   <pubDate>Thu, 23 Jul 2026 12:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02783319</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026</title>
   <link>http://www.streetinsider.com/Globe+Newswire/OPKO+Health+to+Report+Second+Quarter+2026+Financial+Results+on+July+27%2C+2026/26806928.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;MIAMI, July  23, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;OPKO Health, Inc. &lt;/strong&gt;(OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets, today announced that it will report operating and financial results for the second-quarter 2026 on Monday, July 27, 2026. OPKO’s senior management will host a conference call and webcast at 4:30 p.m. ET to provide a business update, discuss results and financial guidance.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;CONFERENCE CALL &amp;amp; WEBCAST INFORMATION&lt;/strong&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;OPKO encourages participants to pre-register for the conference call using this &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=2fF-cG96jNHIfSjLAW-4uUeOcIIEx3e-D6NMKQNVWavJUeWrQPM2wxFcvpv4PZmKMKBkP7psRNguEdsxqrpomrx5UBt1DpxGmO_Y0tJmWB6QQkkxWvlgVrVXWlGszMPQ7colWa5voxT3kZwvYbJjjRKJjDjddUvpJHraynkj9agkfvXQqaXkJuOw_IADhTJ87KPygBEZNM-4kc9FW9n3iw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;link&lt;/a&gt;. Participants</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/OPKO+Health+to+Report+Second+Quarter+2026+Financial+Results+on+July+27%2C+2026/26806928.html</guid>
   <pubDate>Thu, 23 Jul 2026 12:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02783319</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13D/A  OPKO HEALTH, INC.                      Filed by: FROST PHILLIP MD ET AL</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++OPKO+HEALTH%2C+INC.++++++++++++++++++++++Filed+by%3A+FROST+PHILLIP+MD+ET+AL/26720567.html</link>
   <description>si-local-file:///var/storage/secattach/20260701/26720567.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++OPKO+HEALTH%2C+INC.++++++++++++++++++++++Filed+by%3A+FROST+PHILLIP+MD+ET+AL/26720567.html</guid>
   <pubDate>Wed, 01 Jul 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02783319</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13D/A  OPKO HEALTH, INC.                      Filed by: FROST PHILLIP MD ET AL</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++OPKO+HEALTH%2C+INC.++++++++++++++++++++++Filed+by%3A+FROST+PHILLIP+MD+ET+AL/26720567.html</link>
   <description>si-local-file:///var/storage/secattach/20260701/26720567.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++OPKO+HEALTH%2C+INC.++++++++++++++++++++++Filed+by%3A+FROST+PHILLIP+MD+ET+AL/26720567.html</guid>
   <pubDate>Wed, 01 Jul 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02783319</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>Form  4          OPKO HEALTH, INC.         For: Jun 18  Filed by: Lachman Prem A</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+Lachman+Prem+A/26674260.html</link>
   <description>si-local-file:///var/storage/secattach/20260622/26674260.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+Lachman+Prem+A/26674260.html</guid>
   <pubDate>Mon, 22 Jun 2026 17:38:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02783319</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>Form  4          OPKO HEALTH, INC.         For: Jun 18  Filed by: Lachman Prem A</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+Lachman+Prem+A/26674260.html</link>
   <description>si-local-file:///var/storage/secattach/20260622/26674260.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+Lachman+Prem+A/26674260.html</guid>
   <pubDate>Mon, 22 Jun 2026 17:38:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02783319</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>Form  4          OPKO HEALTH, INC.         For: Jun 18  Filed by: MEDEL ROGER MD</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+MEDEL+ROGER+MD/26674256.html</link>
   <description>si-local-file:///var/storage/secattach/20260622/26674256.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+MEDEL+ROGER+MD/26674256.html</guid>
   <pubDate>Mon, 22 Jun 2026 17:37:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02783319</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>Form  4          OPKO HEALTH, INC.         For: Jun 18  Filed by: MEDEL ROGER MD</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+MEDEL+ROGER+MD/26674256.html</link>
   <description>si-local-file:///var/storage/secattach/20260622/26674256.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+MEDEL+ROGER+MD/26674256.html</guid>
   <pubDate>Mon, 22 Jun 2026 17:37:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02783319</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>Form  4          OPKO HEALTH, INC.         For: Jun 18  Filed by: PAGANELLI JOHN A</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+PAGANELLI+JOHN+A/26674254.html</link>
   <description>si-local-file:///var/storage/secattach/20260622/26674254.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+PAGANELLI+JOHN+A/26674254.html</guid>
   <pubDate>Mon, 22 Jun 2026 17:36:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02783319</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>Form  4          OPKO HEALTH, INC.         For: Jun 18  Filed by: PAGANELLI JOHN A</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+PAGANELLI+JOHN+A/26674254.html</link>
   <description>si-local-file:///var/storage/secattach/20260622/26674254.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+PAGANELLI+JOHN+A/26674254.html</guid>
   <pubDate>Mon, 22 Jun 2026 17:36:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02783319</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>Form  4          OPKO HEALTH, INC.         For: Jun 18  Filed by: PFENNIGER RICHARD C JR</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+PFENNIGER+RICHARD+C+JR/26674248.html</link>
   <description>si-local-file:///var/storage/secattach/20260622/26674248.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+PFENNIGER+RICHARD+C+JR/26674248.html</guid>
   <pubDate>Mon, 22 Jun 2026 17:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02783319</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>Form  4          OPKO HEALTH, INC.         For: Jun 18  Filed by: PFENNIGER RICHARD C JR</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+PFENNIGER+RICHARD+C+JR/26674248.html</link>
   <description>si-local-file:///var/storage/secattach/20260622/26674248.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+PFENNIGER+RICHARD+C+JR/26674248.html</guid>
   <pubDate>Mon, 22 Jun 2026 17:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02783319</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>Form  4          OPKO HEALTH, INC.         For: Jun 18  Filed by: UPPALURI SUBBARAO V</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+UPPALURI+SUBBARAO+V/26674241.html</link>
   <description>si-local-file:///var/storage/secattach/20260622/26674241.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+UPPALURI+SUBBARAO+V/26674241.html</guid>
   <pubDate>Mon, 22 Jun 2026 17:33:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02783319</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>Form  4          OPKO HEALTH, INC.         For: Jun 18  Filed by: UPPALURI SUBBARAO V</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+UPPALURI+SUBBARAO+V/26674241.html</link>
   <description>si-local-file:///var/storage/secattach/20260622/26674241.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+UPPALURI+SUBBARAO+V/26674241.html</guid>
   <pubDate>Mon, 22 Jun 2026 17:33:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02783319</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>Form  4          OPKO HEALTH, INC.         For: Jun 18  Filed by: Yu Alice Lin-Tsing</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+Yu+Alice+Lin-Tsing/26674234.html</link>
   <description>si-local-file:///var/storage/secattach/20260622/26674234.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+Yu+Alice+Lin-Tsing/26674234.html</guid>
   <pubDate>Mon, 22 Jun 2026 17:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02783319</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>Form  4          OPKO HEALTH, INC.         For: Jun 18  Filed by: Yu Alice Lin-Tsing</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+Yu+Alice+Lin-Tsing/26674234.html</link>
   <description>si-local-file:///var/storage/secattach/20260622/26674234.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18++Filed+by%3A+Yu+Alice+Lin-Tsing/26674234.html</guid>
   <pubDate>Mon, 22 Jun 2026 17:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02783319</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>Form  8-K        OPKO HEALTH, INC.         For: Jun 18</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18/26665981.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26665981.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18/26665981.html</guid>
   <pubDate>Thu, 18 Jun 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02783319</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>Form  8-K        OPKO HEALTH, INC.         For: Jun 18</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18/26665981.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26665981.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++OPKO+HEALTH%2C+INC.+++++++++For%3A+Jun+18/26665981.html</guid>
   <pubDate>Thu, 18 Jun 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02783319</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>ENTERA BIO shares preclinical data for two pipeline drugs at ENDO 2026</title>
   <link>http://www.streetinsider.com/FDA/ENTERA+BIO+shares+preclinical+data+for+two+pipeline+drugs+at+ENDO+2026/26651078.html</link>
   <description>

&lt;p&gt;Entera Bio Ltd. (NASDAQ: ENTX) presented preclinical data for two pipeline candidates, EB612 and EB618, at ENDO 2026, the annual meeting of the Endocrine Society, on June 16, 2026. Both programs are being co-developed with OPKO Health Inc. (NASDAQ: OPK) on a 50/50 basis.&lt;/p&gt;

&lt;p&gt;EB612 is a long-acting PTH(1-34) analog formulated as an oral tablet for hypoparathyroidism. In a thyroparathyroidectomized rat model, daily dosing for seven days restored serum calcium and reduced phosphate to levels comparable to sham control animals. In a minipig model, a single oral dose reached peak plasma levels two to three hours post-dose, with drug detectable in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/ENTERA+BIO+shares+preclinical+data+for+two+pipeline+drugs+at+ENDO+2026/26651078.html</guid>
   <pubDate>Tue, 16 Jun 2026 08:33:28 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50203974</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ENTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00028300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38505617</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>ENTERA BIO shares preclinical data for two pipeline drugs at ENDO 2026</title>
   <link>http://www.streetinsider.com/FDA/ENTERA+BIO+shares+preclinical+data+for+two+pipeline+drugs+at+ENDO+2026/26651078.html</link>
   <description>

&lt;p&gt;Entera Bio Ltd. (NASDAQ: ENTX) presented preclinical data for two pipeline candidates, EB612 and EB618, at ENDO 2026, the annual meeting of the Endocrine Society, on June 16, 2026. Both programs are being co-developed with OPKO Health Inc. (NASDAQ: OPK) on a 50/50 basis.&lt;/p&gt;

&lt;p&gt;EB612 is a long-acting PTH(1-34) analog formulated as an oral tablet for hypoparathyroidism. In a thyroparathyroidectomized rat model, daily dosing for seven days restored serum calcium and reduced phosphate to levels comparable to sham control animals. In a minipig model, a single oral dose reached peak plasma levels two to three hours post-dose, with drug detectable in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/ENTERA+BIO+shares+preclinical+data+for+two+pipeline+drugs+at+ENDO+2026/26651078.html</guid>
   <pubDate>Tue, 16 Jun 2026 08:33:28 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50203974</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ENTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00028300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38505617</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>ENTERA BIO shares preclinical data for two pipeline drugs at ENDO 2026</title>
   <link>http://www.streetinsider.com/FDA/ENTERA+BIO+shares+preclinical+data+for+two+pipeline+drugs+at+ENDO+2026/26651078.html</link>
   <description>

&lt;p&gt;Entera Bio Ltd. (NASDAQ: ENTX) presented preclinical data for two pipeline candidates, EB612 and EB618, at ENDO 2026, the annual meeting of the Endocrine Society, on June 16, 2026. Both programs are being co-developed with OPKO Health Inc. (NASDAQ: OPK) on a 50/50 basis.&lt;/p&gt;

&lt;p&gt;EB612 is a long-acting PTH(1-34) analog formulated as an oral tablet for hypoparathyroidism. In a thyroparathyroidectomized rat model, daily dosing for seven days restored serum calcium and reduced phosphate to levels comparable to sham control animals. In a minipig model, a single oral dose reached peak plasma levels two to three hours post-dose, with drug detectable in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/ENTERA+BIO+shares+preclinical+data+for+two+pipeline+drugs+at+ENDO+2026/26651078.html</guid>
   <pubDate>Tue, 16 Jun 2026 08:33:28 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50203974</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ENTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00028300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38505617</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>ENTERA BIO shares preclinical data for two pipeline drugs at ENDO 2026</title>
   <link>http://www.streetinsider.com/FDA/ENTERA+BIO+shares+preclinical+data+for+two+pipeline+drugs+at+ENDO+2026/26651078.html</link>
   <description>

&lt;p&gt;Entera Bio Ltd. (NASDAQ: ENTX) presented preclinical data for two pipeline candidates, EB612 and EB618, at ENDO 2026, the annual meeting of the Endocrine Society, on June 16, 2026. Both programs are being co-developed with OPKO Health Inc. (NASDAQ: OPK) on a 50/50 basis.&lt;/p&gt;

&lt;p&gt;EB612 is a long-acting PTH(1-34) analog formulated as an oral tablet for hypoparathyroidism. In a thyroparathyroidectomized rat model, daily dosing for seven days restored serum calcium and reduced phosphate to levels comparable to sham control animals. In a minipig model, a single oral dose reached peak plasma levels two to three hours post-dose, with drug detectable in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/ENTERA+BIO+shares+preclinical+data+for+two+pipeline+drugs+at+ENDO+2026/26651078.html</guid>
   <pubDate>Tue, 16 Jun 2026 08:33:28 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50203974</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ENTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00028300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38505617</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
  <item>
   <title>ENTERA BIO shares preclinical data for two pipeline drugs at ENDO 2026</title>
   <link>http://www.streetinsider.com/FDA/ENTERA+BIO+shares+preclinical+data+for+two+pipeline+drugs+at+ENDO+2026/26651078.html</link>
   <description>

&lt;p&gt;Entera Bio Ltd. (NASDAQ: ENTX) presented preclinical data for two pipeline candidates, EB612 and EB618, at ENDO 2026, the annual meeting of the Endocrine Society, on June 16, 2026. Both programs are being co-developed with OPKO Health Inc. (NASDAQ: OPK) on a 50/50 basis.&lt;/p&gt;

&lt;p&gt;EB612 is a long-acting PTH(1-34) analog formulated as an oral tablet for hypoparathyroidism. In a thyroparathyroidectomized rat model, daily dosing for seven days restored serum calcium and reduced phosphate to levels comparable to sham control animals. In a minipig model, a single oral dose reached peak plasma levels two to three hours post-dose, with drug detectable in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/ENTERA+BIO+shares+preclinical+data+for+two+pipeline+drugs+at+ENDO+2026/26651078.html</guid>
   <pubDate>Tue, 16 Jun 2026 08:33:28 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50203974</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ENTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00028300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38505617</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPK</category>
   	  </item>
 </channel>
</rss>
